Omada Health, Inc. - Common stock, $0.001 par value per share (OMDA)

CUSIP: 68170A108

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+1,602,941
Put/Call ratio
3.4%
SEC-reported price per share
$12.57
Number of holders
139
Value change
+$6,858,048
Number of buys
82
Open additional details 1 more signal available
Number of sells
69
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
59,390,172

Security key

68170A108

Report period

Q1 2026

Institutions

139

Top holders

10

Ownership snapshot

Top reported holders of OMDA - Omada Health, Inc. - Common stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Divisadero Street Capital...
Disclosed value leader
Revelation Alpine, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: Divisadero Street Capital Management, LP Showing 1-6 of 15 holder rows.

Quick read

Divisadero Street Capital Management, LP leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Divisadero Street Capital Management, LP's linked filing trail.
Comparable ownership Top 5
Divisadero Street Capital Managem... 9.9%
Revelation Alpine, LLC 9.1%
Cigna Ventures, LLC 5.8%
FMR LLC 5.6%
Andreessen Horowitz Fund IV, L.P. 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Divisadero Street Capital Management, LP
13D/G 13F
Company
9.9%
$73,773,069
5,887,715 shares
+$10,414,911 31 Mar 2026
Revelation Alpine, LLC
13D/G 3/4/5
Michael Boggs · 10%+ Owner
9.1%
$92,025,961
5,208,034 shares
$0 30 Jun 2025
Cigna Ventures, LLC
13D/G
The Cigna Group
5.8%
$57,180,858
3,444,630 shares
$0 30 Jun 2025
FMR LLC
13F 13D/G
Company
5.6%
from 13D/G
$81,716,794
5,178,504 shares
31 Dec 2025
Andreessen Horowitz Fund IV, L.P.
13D/G
Benjamin A. Horowitz
4.2%
$30,845,214
2,461,709 shares
-$13,521,599 31 Mar 2026
Revelation Capital Management, LLC
13F
Company
13F
8.8%
$82,182,777
5,208,034 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
139
Shares
48,165,328
Rows available
139
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q3 2025 Across Filers

Q3 2025 holders
84
Q1 2026 holders
139
Holder diff
55
Investor Q3 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q3 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .